| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 7.64e-06 | 31 | 82 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 9.94e-05 | 4 | 82 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.44e-04 | 193 | 82 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.61e-04 | 197 | 82 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.91e-04 | 129 | 82 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.47e-04 | 6 | 82 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.79e-04 | 140 | 82 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.95e-04 | 151 | 82 | 5 | GO:0015085 | |
| Domain | Ryanrecept_TM4-6 | 5.84e-05 | 3 | 83 | 2 | IPR009460 | |
| Domain | RyR | 5.84e-05 | 3 | 83 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 5.84e-05 | 3 | 83 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 5.84e-05 | 3 | 83 | 2 | PF06459 | |
| Domain | Ryan_recept | 5.84e-05 | 3 | 83 | 2 | IPR013333 | |
| Domain | RIH_assoc | 2.89e-04 | 6 | 83 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 2.89e-04 | 6 | 83 | 2 | IPR013662 | |
| Domain | RIH_dom | 2.89e-04 | 6 | 83 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.89e-04 | 6 | 83 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.89e-04 | 6 | 83 | 2 | IPR015925 | |
| Domain | - | 2.89e-04 | 6 | 83 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.89e-04 | 6 | 83 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 2.89e-04 | 6 | 83 | 2 | PF08709 | |
| Domain | HMG_box_2 | 6.88e-04 | 9 | 83 | 2 | PF09011 | |
| Domain | MIR | 8.58e-04 | 10 | 83 | 2 | PS50919 | |
| Domain | MIR | 8.58e-04 | 10 | 83 | 2 | PF02815 | |
| Domain | MIR | 8.58e-04 | 10 | 83 | 2 | SM00472 | |
| Domain | MIR_motif | 8.58e-04 | 10 | 83 | 2 | IPR016093 | |
| Pubmed | NRBP1 TBC1D15 MOSPD2 TIAM1 MYO6 DNAJC16 UBTF POLE ARL13B BMS1 VPS13A ASPM GNL2 HEATR1 ZNF512 RPL3 USP6NL TARS1 EDRF1 | 2.03e-09 | 1487 | 84 | 19 | 33957083 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | IPPK LAMA1 BMS1 VPS13A SMC4 ADAMTS15 RNF213 ZBTB41 RPE65 DYNC1H1 USP20 RYR1 COL1A2 | 2.42e-08 | 736 | 84 | 13 | 29676528 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | KRT23 EFCAB5 KAT7 HMGB4 VPS13A RNF213 MICAL3 ZBTB41 HEATR1 NXN RYR1 | 9.52e-08 | 552 | 84 | 11 | 10737800 |
| Pubmed | 1.16e-07 | 332 | 84 | 9 | 25693804 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | KAT7 MYO6 UBTF POLE BMS1 ASPM SMC4 RACGAP1 GEMIN5 DHX57 HEATR1 CMSS1 ZNF512 RPL3 TARS1 DYNC1H1 | 1.33e-07 | 1353 | 84 | 16 | 29467282 |
| Pubmed | UBTF POLE BMS1 GNL2 SMC4 GEMIN5 DHX57 HEATR1 ZNF512 RPL3 DYNC1H1 | 5.05e-07 | 653 | 84 | 11 | 22586326 | |
| Pubmed | KAT7 TBC1D15 CLGN UBTF BMS1 CD109 GNL2 SMC4 RACGAP1 GEMIN5 RNF213 DHX57 MICAL3 HEATR1 DYNC1H1 | 1.69e-06 | 1440 | 84 | 15 | 30833792 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | NRBP1 TIAM1 MYO6 POLE ASPM GNL2 SMC4 RACGAP1 DHX57 HEATR1 NXN RPL3 TARS1 DYNC1H1 | 2.31e-06 | 1284 | 84 | 14 | 17353931 |
| Pubmed | 2.61e-06 | 483 | 84 | 9 | 36912080 | ||
| Pubmed | TDRD15 LIG1 MYO6 DNAJC16 ARL13B BMS1 VPS13A RNF213 RPL3 TARS1 DYNC1H1 | 2.72e-06 | 777 | 84 | 11 | 35844135 | |
| Pubmed | 2.73e-06 | 90 | 84 | 5 | 28535371 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ACAP1 MYO6 UBTF CD109 GNL2 SMC4 RACGAP1 HEATR1 CMSS1 RPL3 USP6NL DYNC1H1 | 2.96e-06 | 949 | 84 | 12 | 36574265 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.29e-06 | 497 | 84 | 9 | 36774506 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 3.46e-06 | 168 | 84 | 6 | 30631154 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 12565913 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9489997 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9192302 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 5.76e-06 | 2 | 84 | 2 | 12640042 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 7556644 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 14592949 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 5.76e-06 | 2 | 84 | 2 | 15894801 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9799464 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9817784 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 38520674 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 5.76e-06 | 2 | 84 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 5.76e-06 | 2 | 84 | 2 | 11500519 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TBC1D15 MYO6 UBTF POLE BMS1 GNL2 SMC4 RACGAP1 GEMIN5 HEATR1 ZNF512 RPL3 TARS1 DYNC1H1 | 7.64e-06 | 1425 | 84 | 14 | 30948266 |
| Pubmed | MOSPD2 TIAM1 UBTF ARL13B BMS1 VPS13A GNL2 RNF213 MICAL3 ZNF512 NSD3 COL1A2 | 8.16e-06 | 1049 | 84 | 12 | 27880917 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO6 UBTF BMS1 CD109 GNL2 SMC4 RACGAP1 HEATR1 CMSS1 RPL3 TARS1 DYNC1H1 NSD3 | 9.75e-06 | 1257 | 84 | 13 | 36526897 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 9.94e-06 | 202 | 84 | 6 | 33005030 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18403125 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11171121 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18313230 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.73e-05 | 3 | 84 | 2 | 9204703 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 7876312 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.73e-05 | 3 | 84 | 2 | 12213830 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 9242641 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.73e-05 | 3 | 84 | 2 | 10788707 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 25239916 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.73e-05 | 3 | 84 | 2 | 7621815 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 18643873 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 11159936 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.73e-05 | 3 | 84 | 2 | 10473538 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.73e-05 | 3 | 84 | 2 | 4600883 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 7635066 | ||
| Pubmed | 2.28e-05 | 234 | 84 | 6 | 36243803 | ||
| Pubmed | 3.03e-05 | 657 | 84 | 9 | 36180527 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 22100703 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 18206662 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 19438210 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23203802 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 3.45e-05 | 4 | 84 | 2 | 23413940 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 9384575 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 9607712 | ||
| Pubmed | The plexin-B1/Rac interaction inhibits PAK activation and enhances Sema4D ligand binding. | 3.45e-05 | 4 | 84 | 2 | 11937491 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23482488 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.77e-05 | 256 | 84 | 6 | 33397691 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 4.54e-05 | 533 | 84 | 8 | 30554943 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 23918386 | ||
| Pubmed | Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. | 5.74e-05 | 5 | 84 | 2 | 11818962 | |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 5.74e-05 | 5 | 84 | 2 | 19011160 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 8.59e-05 | 6 | 84 | 2 | 26025922 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 23463619 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 17699751 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 10444070 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 8.59e-05 | 6 | 84 | 2 | 14592808 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 8.59e-05 | 6 | 84 | 2 | 25966694 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 19009018 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 8.59e-05 | 6 | 84 | 2 | 16844763 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TBC1D15 CLGN MYO6 DNAJC16 POLE SMC4 HEATR1 CMSS1 TARS1 DYNC1H1 | 9.15e-05 | 942 | 84 | 10 | 31073040 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 9.16e-05 | 759 | 84 | 9 | 35915203 | |
| Pubmed | FOXL2 modulates cartilage, skeletal development and IGF1-dependent growth in mice. | 1.08e-04 | 38 | 84 | 3 | 26134413 | |
| Pubmed | 1.13e-04 | 195 | 84 | 5 | 19454010 | ||
| Pubmed | A tissue-specific role for intraflagellar transport genes during craniofacial development. | 1.20e-04 | 7 | 84 | 2 | 28346501 | |
| Pubmed | Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. | 1.20e-04 | 7 | 84 | 2 | 7569905 | |
| Pubmed | KLHL41 stabilizes skeletal muscle sarcomeres by nonproteolytic ubiquitination. | 1.20e-04 | 7 | 84 | 2 | 28826497 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 8858343 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 11860456 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 20962236 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 15252009 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 1.20e-04 | 974 | 84 | 10 | 28675297 | |
| Pubmed | 1.22e-04 | 457 | 84 | 7 | 22190034 | ||
| Pubmed | 1.36e-04 | 41 | 84 | 3 | 21052544 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.52e-04 | 330 | 84 | 6 | 33301849 | |
| Pubmed | Functional dissection of Rab GTPases involved in primary cilium formation. | 1.56e-04 | 43 | 84 | 3 | 17646400 | |
| Pubmed | 1.57e-04 | 638 | 84 | 8 | 33239621 | ||
| Pubmed | 1.57e-04 | 638 | 84 | 8 | 31182584 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 16318909 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 18952892 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 32628936 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.60e-04 | 8 | 84 | 2 | 19033399 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 21441923 | ||
| Pubmed | ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation. | 1.60e-04 | 8 | 84 | 2 | 30563862 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 11784029 | ||
| Interaction | RNF123 interactions | IPPK LAMA1 BMS1 VPS13A SMC4 ADAMTS15 RNF213 GRIK1 ZBTB41 RPE65 DYNC1H1 USP20 RYR1 COL1A2 | 6.28e-06 | 824 | 83 | 14 | int:RNF123 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.52e-05 | 3 | 53 | 2 | 287 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B | TRAF3IP2 FNBP1 MYO6 PACSIN1 TNFSF8 GRB14 ZBTB41 DYNC1H1 RYR1 RYR3 | 1.00e-05 | 554 | 83 | 10 | M2244 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 2.58e-05 | 183 | 83 | 6 | M2993 | |
| Coexpression | GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP | 4.24e-05 | 200 | 83 | 6 | M9437 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | 4.24e-05 | 200 | 83 | 6 | M7143 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN | 4.24e-05 | 200 | 83 | 6 | M7162 | |
| Coexpression | SHEPARD_BMYB_MORPHOLINO_DN | 4.48e-05 | 202 | 83 | 6 | M11840 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 1.25e-05 | 364 | 83 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | KAT7 TBC1D15 SFRP1 MOSPD2 ZNF43 UBTF ASPM SMC4 GEMIN5 GRIK1 KMT2E NSD3 COL1A2 | 1.31e-05 | 801 | 83 | 13 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.95e-05 | 406 | 83 | 9 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | KAT7 SFRP1 TIAM1 ARL13B SEL1L3 ASPM SMC4 GEMIN5 DHX57 HEATR1 CMSS1 ZNF512 USP6NL TARS1 EDRF1 NSD3 NAA16 | 4.86e-05 | 1479 | 83 | 17 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500 | 5.49e-05 | 53 | 83 | 4 | gudmap_developingGonad_P2_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | KAT7 DPYD SFRP1 MOSPD2 ZNF43 UBTF ASPM SMC4 GRIK1 KMT2E NSD3 COL1A2 | 5.54e-05 | 790 | 83 | 12 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | KAT7 SFRP1 MOSPD2 IGFBP1 ZNF43 UBTF ASPM SMC4 GRIK1 KMT2E NSD3 COL1A2 | 6.18e-05 | 799 | 83 | 12 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000 | KRT23 NRBP1 SEMA4D HOXB4 UBL5 IGFBP1 LAMA1 SEL1L3 DIPK1B GRB14 RNF213 GRIK1 | 7.29e-05 | 813 | 83 | 12 | gudmap_developingKidney_e11.5_ureteric bud_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 1.82e-04 | 404 | 83 | 8 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 1.82e-04 | 72 | 83 | 4 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | TRAF3IP2 DDIAS SFRP1 TIAM1 GRK5 LAMA1 SEL1L3 ASPM GRB14 RNF213 COL1A2 | 1.94e-04 | 768 | 83 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.96e-04 | 306 | 83 | 7 | gudmap_developingKidney_e11.5_ureteric bud_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.11e-04 | 413 | 83 | 8 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TRAF3IP2 SFRP1 POLE GRK5 LAMA1 SEL1L3 ASPM RACGAP1 GRB14 RNF213 COL1A2 | 2.56e-04 | 793 | 83 | 11 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | DPYD SFRP1 MOSPD2 IGFBP1 MYO6 ZNF43 UBTF ASPM SMC4 KMT2E COL1A2 | 2.67e-04 | 797 | 83 | 11 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 4.37e-04 | 162 | 83 | 5 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_200 | 4.37e-04 | 162 | 83 | 5 | gudmap_developingKidney_e11.5_ureteric bud_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_500 | 4.48e-04 | 91 | 83 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k5 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24-.Th, 4- 8+ TCRhi 24-/lo, Thymus, avg-3 | 4.49e-04 | 351 | 83 | 7 | GSM399379_500 | |
| ToppCell | (05)_Ciliated-(3)_72hpi|(05)_Ciliated / shred by cell type and Timepoint | 7.08e-08 | 113 | 83 | 6 | eaa5bc8f8183b353ee1e7618e99220eb3684cd60 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.55e-08 | 193 | 83 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.37e-07 | 168 | 83 | 6 | 2d2eab3190374f79f373e31c8b062ff4e1766396 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.37e-07 | 168 | 83 | 6 | df58156721457b34af1e81c0eb8a7243cbbfb303 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-06 | 190 | 83 | 6 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 1.51e-06 | 190 | 83 | 6 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.86e-06 | 197 | 83 | 6 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.97e-06 | 199 | 83 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD8_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 9.07e-06 | 150 | 83 | 5 | 0a65f5e2f4e0b0e822b029e0222b28ba2db89e6d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.10e-05 | 156 | 83 | 5 | 19472ef1642c2ad333aa3ce3675a25c6ab1d4556 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-05 | 163 | 83 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 164 | 83 | 5 | 95b800c78871354c859abaa832d778786ef7bcc0 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 166 | 83 | 5 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 169 | 83 | 5 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 170 | 83 | 5 | 2d5e56eee0c3ce75a9641cc14dee0e0807141c32 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-05 | 170 | 83 | 5 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-05 | 172 | 83 | 5 | 282017db72d0537ac82aecc69393ccde9590be60 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 174 | 83 | 5 | 87fa5deff5c1aabb342d674f05ad17c4c0e50d01 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-05 | 175 | 83 | 5 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-05 | 175 | 83 | 5 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 176 | 83 | 5 | 8960b3b9aca11f6edf990dd35a01bb289c176523 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-05 | 177 | 83 | 5 | 5b8fdf88c3a99c827dd1934beb5be102c411025a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 177 | 83 | 5 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-05 | 179 | 83 | 5 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-05 | 179 | 83 | 5 | 6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-05 | 180 | 83 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-05 | 180 | 83 | 5 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 182 | 83 | 5 | 01ae44b465e509b0aa75ccf61bd9bc0a89d6758c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-05 | 184 | 83 | 5 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 184 | 83 | 5 | 8939b6d795992775df0ff58ed1ec9d421a00bcc4 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-05 | 185 | 83 | 5 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-05 | 185 | 83 | 5 | 6e08e329dfe78818f3df255476492c8b4b0b16e6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-05 | 186 | 83 | 5 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.56e-05 | 186 | 83 | 5 | b999b9bed8357083997cacf5dc64530ddedc056e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-05 | 187 | 83 | 5 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 187 | 83 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 187 | 83 | 5 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-05 | 188 | 83 | 5 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.76e-05 | 189 | 83 | 5 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.83e-05 | 190 | 83 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 191 | 83 | 5 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 191 | 83 | 5 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.98e-05 | 192 | 83 | 5 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-05 | 192 | 83 | 5 | ef86d82e4f04f9f54e821ef496d70fc81072d773 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.05e-05 | 193 | 83 | 5 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 3.13e-05 | 194 | 83 | 5 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.13e-05 | 194 | 83 | 5 | 9a99abc65e7509e7ae8fb392f5ee4b2a83128072 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 3.13e-05 | 194 | 83 | 5 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.13e-05 | 194 | 83 | 5 | d840c1949c328779426c9172e02da09e968f0567 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.13e-05 | 194 | 83 | 5 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-05 | 195 | 83 | 5 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 3.29e-05 | 196 | 83 | 5 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | COPD-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 3.29e-05 | 196 | 83 | 5 | af96fb94886e9395f3e2cd0a293af29229d017fe | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.45e-05 | 198 | 83 | 5 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 198 | 83 | 5 | 2ee8ac82ef1b8ebabc8dd824211bbb471f2af8ac | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-11|World / Primary Cells by Cluster | 3.45e-05 | 198 | 83 | 5 | 672c6faeed54e1397e12c0aac1a5cbd19c684f06 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.53e-05 | 199 | 83 | 5 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.53e-05 | 199 | 83 | 5 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 199 | 83 | 5 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 3.53e-05 | 199 | 83 | 5 | 6a1d84f61e1efaab541910926d6911122372659f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Proliferating-Cycling|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | 322337a5a9cc2de1913ee9258c98ae51fb4bd6bb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | cfe017b4a4d604a553d0a3df9659687f38e9a7af | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-05 | 200 | 83 | 5 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.62e-05 | 200 | 83 | 5 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 200 | 83 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-05 | 200 | 83 | 5 | 63f9481059be608ddc9fe9c7a8f8503fce9755dd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | c784459a62bebec560e79aba83de8611457437bc | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.62e-05 | 200 | 83 | 5 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.62e-05 | 200 | 83 | 5 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 200 | 83 | 5 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.95e-05 | 113 | 83 | 4 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| ToppCell | COVID-19-B_cells-B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.02e-04 | 130 | 83 | 4 | 267b06a0db31e2664cf595cd737402da07ab51cd | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 134 | 83 | 4 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.36e-04 | 140 | 83 | 4 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.52e-04 | 144 | 83 | 4 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.60e-04 | 146 | 83 | 4 | 7748277cf2f12e2930d4f5a22247ab9bc266a954 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 147 | 83 | 4 | 989a48bda98fbff398985397a6b1189a4cbc80e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 147 | 83 | 4 | f6681c849c4c06154548bd29a094f202d1c946c2 | |
| ToppCell | IIH-CD4-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.69e-04 | 148 | 83 | 4 | ec626a44cea83f2a0e5c27fc8182f96446d297ac | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-04 | 151 | 83 | 4 | 5d64655b6b09cc0a6d44629a31048b787a0916c5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.97e-04 | 154 | 83 | 4 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 157 | 83 | 4 | cbb08d5c151f0622123276926a2a15bb7d271e90 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 157 | 83 | 4 | 16581e2399a211633f870dce326c75ff4b6a5fe6 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.22e-04 | 159 | 83 | 4 | 141c3ed35c7d11fcaec4acd9cb37104cc259db25 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 160 | 83 | 4 | 55f599df6e3b7a5a505df4b094c834281311d94a | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 160 | 83 | 4 | 296e53e1e0786346d38db2d4188b9a1c0430627b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-04 | 161 | 83 | 4 | 2165897924c790fec43502283f1df221c56c1e9f | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 2.39e-04 | 162 | 83 | 4 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-04 | 162 | 83 | 4 | 64353d33af0e82ebb7cf2bba74d52ca0586a58fc | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 163 | 83 | 4 | 9f5facfa1864eb63e2f8022ad7379d9252b7a254 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-04 | 163 | 83 | 4 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-04 | 163 | 83 | 4 | 7864e966c228282b4b63c43164dba3faba21026d | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.56e-04 | 165 | 83 | 4 | d8b0a9b6f704b98e8f0412c11739879a26c036e2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 165 | 83 | 4 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.56e-04 | 165 | 83 | 4 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV5/7_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-04 | 165 | 83 | 4 | 207f9ca8839f54710e2112986def4bc7b0ef1a28 | |
| Drug | A-30 | 1.93e-07 | 4 | 84 | 3 | CID003028528 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.35e-05 | 2 | 84 | 2 | ctd:C005147 | |
| Drug | 2-hydroxycarbazole | 4.03e-05 | 3 | 84 | 2 | CID000093551 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 4.03e-05 | 3 | 84 | 2 | CID000080262 | |
| Drug | cis-diammineplatinum(II | 4.03e-05 | 3 | 84 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 4.03e-05 | 3 | 84 | 2 | CID002750949 | |
| Drug | flubendiamide | 4.03e-05 | 3 | 84 | 2 | CID011193251 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 4.03e-05 | 3 | 84 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 4.03e-05 | 3 | 84 | 2 | CID000127713 | |
| Drug | aminodantrolene | 4.03e-05 | 3 | 84 | 2 | CID009570289 | |
| Disease | Colorectal Carcinoma | LIG1 DPYD ACAP1 SFRP1 TIAM1 ZNF43 POLE LAMA1 CD109 VPS13A ADAMTS15 NXN EDRF1 | 5.95e-08 | 702 | 81 | 13 | C0009402 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.23e-05 | 3 | 81 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 1.11e-04 | 6 | 81 | 2 | C1854678 | |
| Disease | Colorectal Neoplasms | 1.17e-04 | 277 | 81 | 6 | C0009404 | |
| Disease | coronary aneurysm | 1.22e-04 | 35 | 81 | 3 | EFO_1000881 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.06e-04 | 8 | 81 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Congenital myopathy (disorder) | 4.83e-04 | 12 | 81 | 2 | C0270960 | |
| Disease | level of Phosphatidylethanolamine (18:2_0:0) in blood serum | 6.63e-04 | 14 | 81 | 2 | OBA_2045143 | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 9.96e-04 | 71 | 81 | 3 | EFO_0004735, EFO_0007965 | |
| Disease | inferior parietal cortex volume measurement | 1.23e-03 | 19 | 81 | 2 | EFO_0010307 | |
| Disease | mortality | 1.34e-03 | 173 | 81 | 4 | EFO_0004352 | |
| Disease | coagulation factor measurement | 1.37e-03 | 20 | 81 | 2 | EFO_0004634 | |
| Disease | Familial aplasia of the vermis | 1.37e-03 | 20 | 81 | 2 | cv:C0431399 | |
| Disease | alcohol drinking | 1.46e-03 | 81 | 81 | 3 | EFO_0004329 | |
| Disease | sudden cardiac arrest | 1.56e-03 | 83 | 81 | 3 | EFO_0004278 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.07e-03 | 195 | 81 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.46e-03 | 670 | 81 | 7 | EFO_0006335, EFO_0006336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLKWYDKAEKVLQHA | 801 | Q7Z4L5 | |
| KKEKLPQVSKSWHNY | 236 | O94805 | |
| EVSKHLYKVWKKIGI | 406 | P39086 | |
| PKWVKLRKNHSEKKS | 141 | Q9BQ75 | |
| TSAKKLDKKHWKRNP | 31 | Q12882 | |
| KEAWIHAKYVEKKFL | 506 | Q15027 | |
| DKSIKKGLYWLLHVI | 176 | Q3SXY8 | |
| HLKTLLWKKISNTKY | 416 | Q5VUD6 | |
| LKKHRWYKKILKSRD | 926 | Q14692 | |
| TWRKYKLKTDLKRHQ | 1276 | Q8IZT6 | |
| QKKLNKVSDKHPEYW | 296 | Q8TE58 | |
| HLKVATGKWKQISKY | 166 | Q9H8X2 | |
| KYWKGKHLVLKRQDL | 566 | O95251 | |
| HKLKSKLNYWKAKAL | 51 | Q7RTP6 | |
| HIETYLKKEKPWKHL | 236 | Q13823 | |
| DQKWQRKKKSKEHWY | 186 | Q3B7T1 | |
| RKKKSKEHWYQKAIL | 191 | Q3B7T1 | |
| WLIYKNTKLVKKIDH | 431 | Q9H2S1 | |
| SKALHVTNIKKWKEP | 161 | P08833 | |
| KIYKHIGNLKEAAKW | 416 | Q6N069 | |
| KKKTHKYNCKSSGWI | 931 | Q8IXT1 | |
| KKAYKKLAREWHPDK | 46 | Q9Y2G8 | |
| IIKKKHRDLDTWYKE | 251 | Q9C075 | |
| KYPKTKKHLVNEWLS | 726 | Q8IZD2 | |
| WLHKKLLEKNDVYKQ | 1166 | Q07864 | |
| VKHWYKECERKLKPK | 546 | P29728 | |
| TLHWKKYDIYEKQTK | 396 | P78552 | |
| KIWKEKFKQHEEYIR | 241 | Q96JM4 | |
| PRIKNKSKLQYWLHT | 961 | Q8TCU5 | |
| KFHKYWADIKENKAR | 131 | Q9UHY1 | |
| EKVKNWQKDAYHKQI | 111 | Q9BY11 | |
| KWKKDHKLPNTKIRS | 216 | P17483 | |
| LKSKPEHTWKKNLFE | 106 | A4FU69 | |
| IPAKNWYRSSKDKKH | 1211 | P08123 | |
| KNKIKLYWSKVKAEP | 556 | Q6YHK3 | |
| KHTQWGIDILEKYIK | 16 | Q96RU3 | |
| KKISKRYDWQAKSVH | 501 | Q6P158 | |
| WAEEYSEKKKGSHKR | 256 | Q6P1L5 | |
| KVQSKVNLKYDSWHK | 1111 | Q14204 | |
| LHAKEQGKKSWKKIY | 241 | Q14449 | |
| IKKTYKQIEKNWKNH | 1826 | Q9H583 | |
| KSKKWKEILKFPHIS | 26 | P34947 | |
| AKRSHNWLKLKKDYL | 736 | P18858 | |
| HPYKSKKAVWHKLLS | 3611 | P21817 | |
| KRWAKPKITTEKKNH | 61 | Q9H2U6 | |
| KLFWIRVKYHVKDQK | 106 | Q8NHP6 | |
| KIKALKIHKNSSTYW | 271 | P26639 | |
| GVWLHIADKKRKKYL | 286 | Q16518 | |
| PVYKKRWKNEKHLHT | 126 | Q68CR1 | |
| KNTLKWHRSKVEEKY | 1586 | B5MCY1 | |
| EKHRKLKLWNKYRIS | 116 | Q6DKJ4 | |
| KGYKGVTSRWHTKKL | 226 | P39023 | |
| SEKWRSISKHEKAKY | 46 | Q8WW32 | |
| KWHTVKTDYVKRKGF | 2796 | P25391 | |
| KQHEVYWKVSEDKKA | 81 | Q92854 | |
| KSQYLLTAIHKWDKK | 276 | Q8N474 | |
| RKKWQRTDHELGKYK | 41 | Q9H0H5 | |
| KVCTHPRKKWVQKYI | 71 | Q9Y258 | |
| THVYSWPKNKKNILL | 536 | O43734 | |
| LITSFCWPRKVKKKH | 486 | O14967 | |
| CWPRKVKKKHKDTEY | 491 | O14967 | |
| WPIKKAASYHRKKLE | 131 | Q5EBN2 | |
| HLKKLWKALDKDQYL | 1491 | Q63HN8 | |
| LKGWEKYKNTEKFHR | 81 | Q92738 | |
| KKSWAYLQVAKHLNK | 96 | P32971 | |
| SWKHIRKHRQKVKQY | 351 | Q96RL7 | |
| LLSKWKAVYKQTHSK | 71 | Q8N8B7 | |
| NKKVESATRRKWKHY | 451 | Q13009 | |
| ENYHNIWAKKKKLEL | 2741 | Q15413 | |
| LTAYQAWKLKHQKKV | 586 | Q5VZP5 | |
| KIVLKKWYTIFKDHV | 41 | Q9BZL1 | |
| KSVHLGEKVWQKYKA | 651 | Q5SVQ8 | |
| SIKYKLPVHTEISWK | 531 | Q8TEQ6 | |
| KIKYWHKEISKISLH | 1031 | Q9NTJ3 | |
| HTKWLNKRKIKAFYS | 696 | P55017 | |
| AIHHWKKIKKDPYTA | 231 | Q8TC07 | |
| SYQKLVSEVWHKKRP | 191 | Q9Y2K6 | |
| DCKAGKKLHYKQIVW | 951 | Q9BZ95 | |
| KKLHYKQIVWVKLGN | 956 | Q9BZ95 | |
| GKAFKWSSKLTEHKI | 516 | P17038 | |
| HQDFPVKKRKKLSTW | 126 | Q96N20 | |
| SEKWNYKKHTKEFPT | 86 | Q7Z2W7 | |
| QWKLLSQKEKDAYHK | 331 | P17480 | |
| EVLHKWKTDIKKYHR | 391 | Q96ME7 | |
| GKAFKWLSKLTVHKV | 886 | A6NN14 | |
| RRLKVYHAWKSKNKK | 1116 | Q9UM54 | |
| YHAWKSKNKKRNTET | 1121 | Q9UM54 | |
| SDAHYKADWKKTIAK | 1536 | P20929 |